|
1
|
Yang Y, Meng WJ and Wang ZQ: MicroRNAs in
colon and rectal cancer-novel biomarkers from diagnosis to therapy.
Endocr Metab Immune Disord Drug Targets. 20:1211–2126.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD, Goding Sauer A,
Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal
A: Colorectal cancer statistics, 2020. CA Cancer J Clin.
70:145–164. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–49.
2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Johdi NA and Sukor NF: Colorectal cancer
immunotherapy: options and strategies. Front Immunol.
11(1624)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Piawah S and Venook AP: Targeted therapy
for colorectal cancer metastases: A review of current methods of
molecularly targeted therapy and the use of tumor biomarkers in the
treatment of metastatic colorectal cancer. Cancer. 125:4139–4147.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
De Rosa M, Pace U, Rega D, Costabile V,
Duraturo F, Izzo P and Delrio P: Genetics, diagnosis and management
of colorectal cancer (review). Oncol Rep. 34:1087–1096.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Keller DS, Windsor A, Cohen R and Chand M:
Colorectal cancer in inflammatory bowel disease: Review of the
evidence. Tech Coloproctol. 23:3–13. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Soltani G, Poursheikhani A, Yassi M,
Hayatbakhsh A, Kerachian M and Kerachian MA: Obesity, diabetes and
the risk of colorectal adenoma and cancer. BMC Endocr Disord.
19(113)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ji H, Wang J, Guo J, Li Y, Lian S, Guo W,
Yang H, Kong F, Zhen L, Guo L and Liu Y: Progress in the biological
function of alpha-enolase. Anim Nutr. 2:12–17. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Huang CK, Sun Y, Lv L and Ping Y: ENO1 and
cancer. Mol Ther Oncolytics. 24:288–298. 2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Qiao G, Wu A, Chen X, Tian Y and Lin X:
Enolase 1, a moonlighting protein, as a potential target for cancer
treatment. Int J Biol Sci. 17:3981–3992. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hu T, Liu H, Liang Z, Wang F, Zhou C,
Zheng X, Zhang Y, Song Y, Hu J, He X, et al: Tumor-intrinsic CD47
signal regulates glycolysis and promotes colorectal cancer cell
growth and metastasis. Theranostics. 10:4056–4072. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gu J, Zhong K, Wang L, Ni H, Zhao Y, Wang
X, Yao Y, Jiang L, Wang B and Zhu X: ENO1 contributes to
5-fluorouracil resistance in colorectal cancer cells via EMT
pathway. Front Oncol. 12(1013035)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhan P, Wang Y, Zhao S, Liu C, Wang Y, Wen
M, Mao JH, Wei G and Zhang P: FBXW7 negatively regulates ENO1
expression and function in colorectal cancer. Lab Inves.
95:995–1004. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ahmad R, Singh JK, Wunnava A, Al-Obeed O,
Abdulla M and Srivastava SK: Emerging trends in colorectal cancer:
Dysregulated signaling pathways (review). Int J Mol Med.
47(14)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Leiphrakpam PD, Rajappa SJ, Krishnan M,
Batra R, Murthy SS and Are C: Colorectal cancer: Review of
signaling pathways and associated therapeutic strategies. J Surg
Oncol. 127:1277–1295. 2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Martini M, De Santis MC, Braccini L,
Gulluni F and Hirsch E: PI3K/AKT signaling pathway and cancer: An
updated review. Ann Med. 46:372–383. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yu H, Lee H, Herrmann A, Buettner R and
Jove R: Revisiting STAT3 signalling in cancer: New and unexpected
biological functions. Nat Rev Cancer. 14:736–746. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Li D, Wang G, Jin G, Yao K, Zhao Z, Bie L,
Guo Y, Li N, Deng W, Chen X, et al: Resveratrol suppresses colon
cancer growth by targeting the AKT/STAT3 signaling pathway. Int J
Mol Med. 43:630–640. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xue J, Ge X, Zhao W, Xue L, Dai C, Lin F
and Peng W: PIPKIγ regulates CCL2 expression in colorectal cancer
by activating AKT-STAT3 signaling. J Immunol Res.
2019(3690561)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sun L, Lu T, Tian K, Zhou D, Yuan J, Wang
X, Zhu Z, Wan D, Yao Y, Zhu X and He S: Alpha-enolase promotes
gastric cancer cell proliferation and metastasis via regulating AKT
signaling pathway. Eur J Pharmacol. 845:8–15. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fuhr L, El-Athman R, Scrima R, Cela O,
Carbone A, Knoop H, Li Y, Hoffmann K, Laukkanen MO, Corcione F, et
al: The circadian clock regulates metabolic phenotype rewiring via
HKDC1 and modulates tumor progression and drug response in
colorectal cancer. EBioMedicine. 33:105–121. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen M, Tan AH and Li J: Curcumin
represses colorectal cancer cell proliferation by triggering
ferroptosis via PI3K/Akt/mTOR signaling. Nutr Cancer. 75:726–733.
2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wang Y, Zhang Z, Sun W, Zhang J, Xu Q,
Zhou X and Mao L: Ferroptosis in colorectal cancer: Potential
mechanisms and effective therapeutic targets. Biomed Pharmacother.
153(113524)2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Duan L, Yang W, Wang X, Zhou W, Zhang Y,
Liu J, Zhang H, Zhao Q, Hong L and Fan D: Advances in prognostic
markers for colorectal cancer. Expert Rev Mol Diagn. 19:313–324.
2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Deka D, Scarpa M, Das A, Pathak S and
Banerjee A: Current understanding of epigenetics driven therapeutic
strategies in colorectal cancer management. Endocr Metab Immune
Disord Drug Targets. 21:1882–1894. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kim MS, Kim D and Kim JR: Stage-dependent
gene expression profiling in colorectal cancer. IEEE/ACM Trans
Comput Biol Bioinform. 16:1685–1692. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhan P, Zhao S, Yan H, Yin C, Xiao Y, Wang
Y, Ni R, Chen W, Wei G and Zhang P: α-Enolase promotes
tumorigenesis and metastasis via regulating AMPK/mTOR pathway in
colorectal cancer. Mol Carcinog. 56:1427–1437. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Cheng Z, Shao X, Xu M, Zhou C and Wang J:
ENO1 acts as a prognostic biomarker candidate and promotes tumor
growth and migration ability through the regulation of Rab1A in
colorectal cancer. Cancer Manag Res. 11:9969–9978. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Finley LWS: What is cancer metabolism?
Cell. 186:1670–1688. 2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ganapathy-Kanniappan S: Molecular
intricacies of aerobic glycolysis in cancer: Current insights into
the classic metabolic phenotype. Crit Rev Biochem Mol Biol.
53:667–682. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Nenkov M, Ma Y, Gaßler N and Chen Y:
Metabolic reprogramming of colorectal cancer cells and the
microenvironment: Implication for therapy. Int J Mol Sci.
22(6262)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zafari N, Velayati M, Damavandi S, Pourali
G, Mobarhan MG, Nassiri M, Hassanian SM, Khazaei M, Ferns GA and
Avan A: Metabolic pathways regulating colorectal cancer: A
potential therapeutic approach. Curr Pharm Des. 28:2995–3009.
2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhou J, Zhang S, Chen Z, He Z, Xu Y and Li
Z: CircRNA-ENO1 promoted glycolysis and tumor progression in lung
adenocarcinoma through upregulating its host gene ENO1. Cell Death
Dis. 10(885)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
He Y, Liu Y, Wu D, Chen L, Luo Z, Shi X,
Li K, Hu H, Qu G, Zhao Q and Lian C: Linc-UROD stabilizes ENO1 and
PKM to strengthen glycolysis, proliferation and migration of
pancreatic cancer cells. Transl Oncol. 27(101583)2023.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Qian X, Xu W, Xu J, Shi Q, Li J, Weng Y,
Jiang Z, Feng L, Wang X, Zhou J and Jin H: Enolase 1 stimulates
glycolysis to promote chemoresistance in gastric cancer.
Oncotarget. 8:47691–47708. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Kooshki L, Mahdavi P, Fakhri S, Akkol EK
and Khan H: Targeting lactate metabolism and glycolytic pathways in
the tumor microenvironment by natural products: A promising
strategy in combating cancer. Biofactors. 48:359–383.
2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Cao S, Chen Y, Ren Y, Feng Y and Long S:
GLUT1 biological function and inhibition: research advances. Future
Med Chem. 13:1227–1243. 2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Li Z and Zhang H: Reprogramming of
glucose, fatty acid and amino acid metabolism for cancer
progression. Cell Mol Life Sci. 73:377–392. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Jiang X, Stockwell BR and Conrad M:
Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol
Cell Biol. 22:266–282. 2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Gao M, Yi J, Zhu J, Minikes AM, Monian P,
Thompson CB and Jiang X: Role of mitochondria in ferroptosis. Mol
Cell. 73:354–363.e3. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yang L, Zhang Y, Zhang Y and Fan Z:
Mechanism and application of ferroptosis in colorectal cancer.
Biomed Pharmacother. 158(114102)2023.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Zhang T, Sun L, Hao Y, Suo C, Shen S, Wei
H, Ma W, Zhang P, Wang T, Gu X, et al: ENO1 suppresses cancer cell
ferroptosis by degrading the mRNA of iron regulatory protein 1. Nat
Cancer. 3:75–89. 2022.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Asantewaa G and Harris IS: Glutathione and
its precursors in cancer. Curr Opin Biotechnol. 68:292–299.
2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Tsikas D: Assessment of lipid peroxidation
by measuring malondialdehyde (MDA) and relatives in biological
samples: Analytical and biological challenges. Anal Biochem.
524:13–30. 2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Zhang F, Li Z, Gao P, Zou J, Cui Y, Qian
Y, Gu R, Xu W and Hu J: HJ11 decoction restrains development of
myocardial ischemia-reperfusion injury in rats by suppressing
ACSL4-mediated ferroptosis. Front Pharmacol.
13(1024292)2022.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Hao J, Zhang W and Huang Z: Bupivacaine
modulates the apoptosis and ferroptosis in bladder cancer via
phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Bioengineered.
13:6794–6806. 2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Wang D, Jin X, Lei M, Jiang Y, Liu Y, Yu
F, Guo Y, Han B, Yang Y, Sun W, et al: USF1-ATRAP-PBX3 axis promote
breast cancer glycolysis and malignant phenotype by activating
AKT/mTOR signaling. Int J Biol Sci. 18:2452–2471. 2022.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Chen Y, Wang F, Wu P, Gong S, Gao J, Tao
H, Shen Q, Wang S, Zhou Z and Jia Y: Artesunate induces apoptosis,
autophagy and ferroptosis in diffuse large B cell lymphoma cells by
impairing STAT3 signaling. Cell Signal. 88(110167)2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Li YJ, Zhang C, Martincuks A, Herrmann A
and Yu H: STAT proteins in cancer: orchestration of metabolism. Nat
Rev Cancer. 23:115–134. 2023.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Sun Z, Jiang Q, Gao B, Zhang X, Bu L, Wang
L, Lin Y, Xie W, Li J and Guo J: AKT blocks SIK1-mediated
repression of STAT3 to promote breast tumorigenesis. Cancer Res.
83:1264–1279. 2023.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Li M, Zhao X, Yong H, Xu J, Qu P, Qiao S,
Hou P, Li Z, Chu S, Zheng J and Bai J: Transketolase promotes
colorectal cancer metastasis through regulating AKT
phosphorylation. Cell Death Dis. 13(99)2022.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Li Y, Wang Y, Liu Z, Guo X, Miao Z and Ma
S: Atractylenolide I induces apoptosis and suppresses glycolysis by
blocking the JAK2/STAT3 signaling pathway in colorectal cancer
cells. Front Pharmacol. 11(273)2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Zhao X and Chen F: Propofol induces the
ferroptosis of colorectal cancer cells by downregulating STAT3
expression. Oncol Lett. 22(767)2021.PubMed/NCBI View Article : Google Scholar
|
